OPNT - Opiant Pharmaceuticals beats by $0.35 beats on revenue May, 09 2019 04:39 PM Opiant Pharmaceuticals Inc. Opiant Pharmaceuticals (NASDAQ:OPNT): Q1 GAAP EPS of -$0.44 beats by $0.35.More news on: Opiant Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...